Working... Menu

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira (REMITiDegLira)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03862716
Recruitment Status : Recruiting
First Posted : March 5, 2019
Last Update Posted : June 5, 2019
Novo Nordisk A/S
Information provided by (Responsible Party):
Population Health Research Institute

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 30, 2020
  Estimated Study Completion Date : December 31, 2021